NCT02153281 Neuroimaging MAO-B in Medication Free TR-MDD Using Novel Tracer Status COMPLETED Phase NA
NCT02150681 Mindfulness-Based Cognitive Therapy for Perinatal Women With Mood Disorders Status COMPLETED Phase PHASE1
NCT02149836 Study to Treat Major Depressive Disorder (MDD) With a New Medication Status COMPLETED Phase PHASE2
NCT02149810 Automatic Self Transcending Meditation Versus Treatment as Usual Status COMPLETED Phase NA
NCT02141776 Comparison of Anodal Transcranial Direct Current Stimulation (t-DCS) and Sham Stimulation in Patients With Treatment-resistant Depression Status COMPLETED Phase PHASE4
NCT02139540 Nitrous Oxide as Treatment for Major Depression - a Pilot Study Status COMPLETED Phase PHASE2
NCT02134808 Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive Disorder Status COMPLETED Phase PHASE4
NCT02133001 A Double-blind Study to Assess the Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Participants Who Are Assessed to be at Imminent Risk for Suicide Status COMPLETED Phase PHASE2
NCT02132286 Serotonin Transporter Genetic Variation and Amygdala Responses to Antidepressant Medications in Major Depression Status COMPLETED Phase PHASE4
NCT02129751 Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder Status NOT_YET_RECRUITING Phase PHASE4
NCT02125799 Accelerated rTMS for Treatment-Resistant Major Depression Status COMPLETED Phase PHASE2/PHASE3
NCT02120729 Pharmacogenetic Decision Support IT System for Psychiatric Hospitalization: RCT Status UNKNOWN Phase NA
NCT02099630 Functional and Metabolic Changes in the Course of Antidepressive Treatment Status COMPLETED Phase N/A
NCT02085135 A Study of Different Titration Schedules of ALKS 5461 in Adults With Major Depressive Disorder (MDD) Status COMPLETED Phase PHASE3
NCT02079610 Effect of Amygdala Neurofeedback on Depressive Symptoms and Processing Biases Status COMPLETED Phase NA
NCT02078817 Ketamine in Adolescents With Treatment-Resistant Depression Status COMPLETED Phase PHASE2